Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III
CONCLUSIONS: SABA over-prescription was reported in nearly 50% of patients prescribed SABA in addition to maintenance therapy, underscoring the need to align clinical practices with the latest evidence-based recommendations and educate physicians and patients on appropriate SABA use.PMID:38057957 | DOI:10.3904/kjim.2023.086
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Kwang-Ha Yoo Sang-Ha Kim Sang-Heon Kim Ji-Yong Moon Heung-Woo Park Yoon-Seok Chang Maarten J H I Beekman Source Type: research
More News: Asthma | Corticosteroid Therapy | Education | Internal Medicine | South Korea Health | Study